Genocea Biosciences

Genocea Biosciences

Genocea Biosciences

Harnessing T cells to save and improve millions of lives
Founded
2006
Raised
$145.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$51,700,000
Post-IPO equity - 2015
$27,000,000
Post-IPO debt - 2014
Team Size
50+
Employees
Xconomy

Genocea Touts Early Look at Placebo-Controlled Herpes Vaccine Study

Health
The Motley Fool

Why It's Been a Wild Few Days for Genocea Biosciences Inc.

Health Stock markets
Xconomy

Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall

Health